- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05249166
Feeding for Accesible, Affordable and Healthy Childhood (ALINFA)
February 18, 2022 updated by: Clinica Universidad de Navarra, Universidad de Navarra
The main objective of this study was to evaluate the effectiveness of implementing a healthy eating vs traditional recommendations on the Medkid index of children in primary school.
To do so, different companies involved in ALINFA project developed with the assessment of UNAV, CNTA and UPNA, a healthy bi-weekly menu.
Study Overview
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Navarra
-
Pamplona, Navarra, Spain, 31008
- Center for Nutrition Research. University of Navarra
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 12 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adequate cultural level and comprehension of the clinical study from the legal tutors.
- To agree in taking part of the study.
Exclusion Criteria:
- Children presenting clinically relevant gastrointestinal malfunctions or structural anomalies, such as ulcers, chronic inflammatory diseases, etc. Even if they do not follow any pharmacological treatment at the moment of inclusion.
- Children with uncontrolled endocrine disorders.
- Children with any type of tumor/cancer within the last 5 years, or in current treatment.
- Children with any alimentary allergy.
- Children presenting any type of cognitive or psychic disorder
- Parents or legal tutors in which their future collaboration may not be the required, seen from the researchers' point of view.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Control group
Subjects assigned to this arm will follow the habitual recommendations to develop skills for a healthy diet.
No specific foods or cooking methods will be applied
|
control group
|
EXPERIMENTAL: ALINFA group
This group will receive, in addition to the usual recommendations, meals, and foods designed to increase the healthiness of the diet.
Foods and meals have been designed to increase the fiber content, decrease sugars and saturated fats, and limit salt intake.
|
Comparing the usual recommendations with the healthy diet designed and developed
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dietary Pattern (questionnaire)
Time Frame: Baseline
|
Evaluate differences in dietary pattern between groups
|
Baseline
|
Dietary pattern (questionnaire)
Time Frame: 8 week
|
Evaluate differences in dietary pattern between groups
|
8 week
|
Dietary pattern (questionnaire)
Time Frame: Baseline vs 8 week
|
Evaluated changes in dietary pattern
|
Baseline vs 8 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Santiago Navas Carretero, PhD, University of Navarra
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 15, 2021
Primary Completion (ACTUAL)
December 10, 2021
Study Completion (ACTUAL)
December 10, 2021
Study Registration Dates
First Submitted
December 9, 2021
First Submitted That Met QC Criteria
February 18, 2022
First Posted (ACTUAL)
February 21, 2022
Study Record Updates
Last Update Posted (ACTUAL)
February 21, 2022
Last Update Submitted That Met QC Criteria
February 18, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- ALINFA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Children
-
University of Illinois at Urbana-ChampaignSoy Nutrition InstituteRecruiting
-
Arkansas Children's Hospital Research InstituteActive, not recruiting
-
Zhang DongCompleted
-
Danone NutriciaNutricia Early Life Nutrition (Shanghai) Co., LtdCompleted
-
Green Cross CorporationCompleted
-
Shenandoah UniversityCompletedHealthy ChildrenUnited States
-
Cliniques universitaires Saint-Luc- Université...CompletedHealthy ChildrenBelgium
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Danone NutriciaNot yet recruiting
-
Indonesian Nutrition AssociationRecruitingHealthy ChildrenIndonesia
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted